Rituximab-mediated late onset neutropenia in autoimmune blistering diseases: negligible or under-estimated threat?
Christine HospMatthias GoebelerSandrine BenoitJohanna StoevesandtPublished in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2020)